IS5166A - Crystallized aqueous sodium salt of (E) -4,6-dichloro-3- (2-oxo-1-phenylpyrrolidin-3-ylidene methyl) -1H-indole-2-carboxylic acid - Google Patents
Crystallized aqueous sodium salt of (E) -4,6-dichloro-3- (2-oxo-1-phenylpyrrolidin-3-ylidene methyl) -1H-indole-2-carboxylic acidInfo
- Publication number
- IS5166A IS5166A IS5166A IS5166A IS5166A IS 5166 A IS5166 A IS 5166A IS 5166 A IS5166 A IS 5166A IS 5166 A IS5166 A IS 5166A IS 5166 A IS5166 A IS 5166A
- Authority
- IS
- Iceland
- Prior art keywords
- phenylpyrrolidin
- indole
- dichloro
- oxo
- carboxylic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9704498.6A GB9704498D0 (en) | 1997-03-05 | 1997-03-05 | Chemical compound |
| PCT/EP1998/001146 WO1998039327A1 (en) | 1997-03-05 | 1998-03-03 | Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS5166A true IS5166A (en) | 1999-08-27 |
Family
ID=10808697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS5166A IS5166A (en) | 1997-03-05 | 1999-08-27 | Crystallized aqueous sodium salt of (E) -4,6-dichloro-3- (2-oxo-1-phenylpyrrolidin-3-ylidene methyl) -1H-indole-2-carboxylic acid |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP0966463A1 (en) |
| JP (1) | JP2001513796A (en) |
| KR (1) | KR20000075907A (en) |
| CN (1) | CN1249750A (en) |
| AP (1) | AP9901637A0 (en) |
| AR (1) | AR011178A1 (en) |
| AU (1) | AU6825198A (en) |
| BG (1) | BG103779A (en) |
| BR (1) | BR9808305A (en) |
| CA (1) | CA2282851A1 (en) |
| CO (1) | CO4940415A1 (en) |
| EA (1) | EA199900710A1 (en) |
| EE (1) | EE9900387A (en) |
| GB (1) | GB9704498D0 (en) |
| HR (1) | HRP980114A2 (en) |
| HU (1) | HUP0002109A2 (en) |
| ID (1) | ID24207A (en) |
| IL (1) | IL131489A0 (en) |
| IS (1) | IS5166A (en) |
| NO (1) | NO994303L (en) |
| NZ (1) | NZ337315A (en) |
| OA (1) | OA11154A (en) |
| PE (1) | PE51399A1 (en) |
| PL (1) | PL335652A1 (en) |
| SK (1) | SK119699A3 (en) |
| TR (1) | TR199902117T2 (en) |
| WO (1) | WO1998039327A1 (en) |
| YU (1) | YU43499A (en) |
| ZA (1) | ZA981791B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9704499D0 (en) * | 1997-03-05 | 1997-04-23 | Glaxo Wellcome Spa | Method of manufacture |
| GB9825988D0 (en) * | 1998-11-27 | 1999-01-20 | Pfizer Ltd | Indole derivatives |
| GB9915231D0 (en) | 1999-06-29 | 1999-09-01 | Pfizer Ltd | Pharmaceutical complex |
| US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| MX2019015120A (en) | 2017-06-12 | 2022-07-14 | Glytech Llc | Treatment of depression with nmda antagonists and d2/5ht2a or selective 5ht2a antagonists. |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9321221D0 (en) * | 1993-10-14 | 1993-12-01 | Glaxo Spa | Heterocyclic compounds |
-
1997
- 1997-03-05 GB GBGB9704498.6A patent/GB9704498D0/en active Pending
-
1998
- 1998-03-03 AU AU68251/98A patent/AU6825198A/en not_active Abandoned
- 1998-03-03 CA CA002282851A patent/CA2282851A1/en not_active Abandoned
- 1998-03-03 KR KR1019997007987A patent/KR20000075907A/en not_active Application Discontinuation
- 1998-03-03 EE EEP199900387A patent/EE9900387A/en unknown
- 1998-03-03 JP JP53813598A patent/JP2001513796A/en active Pending
- 1998-03-03 BR BR9808305-8A patent/BR9808305A/en not_active Application Discontinuation
- 1998-03-03 IL IL13148998A patent/IL131489A0/en unknown
- 1998-03-03 AR ARP980100948A patent/AR011178A1/en unknown
- 1998-03-03 EA EA199900710A patent/EA199900710A1/en unknown
- 1998-03-03 PL PL98335652A patent/PL335652A1/en unknown
- 1998-03-03 SK SK1196-99A patent/SK119699A3/en unknown
- 1998-03-03 PE PE1998000149A patent/PE51399A1/en not_active Application Discontinuation
- 1998-03-03 EP EP98913613A patent/EP0966463A1/en not_active Withdrawn
- 1998-03-03 HU HU0002109A patent/HUP0002109A2/en unknown
- 1998-03-03 WO PCT/EP1998/001146 patent/WO1998039327A1/en not_active Application Discontinuation
- 1998-03-03 YU YU43499A patent/YU43499A/en unknown
- 1998-03-03 NZ NZ337315A patent/NZ337315A/en unknown
- 1998-03-03 CO CO98011404A patent/CO4940415A1/en unknown
- 1998-03-03 CN CN98803053A patent/CN1249750A/en active Pending
- 1998-03-03 AP APAP/P/1999/001637A patent/AP9901637A0/en unknown
- 1998-03-03 TR TR1999/02117T patent/TR199902117T2/en unknown
- 1998-03-03 ID IDW990976A patent/ID24207A/en unknown
- 1998-03-03 ZA ZA9801791A patent/ZA981791B/en unknown
- 1998-03-04 HR HR9704498.6A patent/HRP980114A2/en not_active Application Discontinuation
-
1999
- 1999-08-27 IS IS5166A patent/IS5166A/en unknown
- 1999-09-02 OA OA9900201A patent/OA11154A/en unknown
- 1999-09-03 NO NO994303A patent/NO994303L/en not_active Application Discontinuation
- 1999-10-04 BG BG103779A patent/BG103779A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR9808305A (en) | 2000-05-16 |
| YU43499A (en) | 2000-12-28 |
| EE9900387A (en) | 2000-04-17 |
| OA11154A (en) | 2003-04-16 |
| PL335652A1 (en) | 2000-05-08 |
| PE51399A1 (en) | 1999-06-07 |
| ZA981791B (en) | 1999-09-03 |
| CO4940415A1 (en) | 2000-07-24 |
| TR199902117T2 (en) | 2000-03-21 |
| AU6825198A (en) | 1998-09-22 |
| NO994303L (en) | 1999-11-03 |
| IL131489A0 (en) | 2001-01-28 |
| EP0966463A1 (en) | 1999-12-29 |
| KR20000075907A (en) | 2000-12-26 |
| NZ337315A (en) | 2001-02-23 |
| ID24207A (en) | 2000-07-13 |
| JP2001513796A (en) | 2001-09-04 |
| GB9704498D0 (en) | 1997-04-23 |
| AP9901637A0 (en) | 1999-09-30 |
| WO1998039327A1 (en) | 1998-09-11 |
| HRP980114A2 (en) | 1998-12-31 |
| EA199900710A1 (en) | 2000-04-24 |
| NO994303D0 (en) | 1999-09-03 |
| CA2282851A1 (en) | 1998-09-11 |
| HUP0002109A2 (en) | 2001-04-28 |
| AR011178A1 (en) | 2000-08-02 |
| BG103779A (en) | 2000-06-30 |
| SK119699A3 (en) | 2000-05-16 |
| CN1249750A (en) | 2000-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0991641T3 (en) | Crystalline form of omeprazole sodium salt | |
| DE59912742D1 (en) | SUBSTITUTED PYRAZONE DERIVATIVES | |
| PT1077957E (en) | OXY-IMINOALCANOIC ACID DERIVATIVES | |
| NO20005084L (en) | Heterocyclic glycyl <beta> -alanine derivatives as vitronectin antagonists | |
| PT1163237E (en) | AMIDA DERIVATIVES | |
| EE200000720A (en) | Novel 3-aryl-2-hydroxypropanoic acid derivative (I) | |
| AR028280A1 (en) | DERIVATIVES OF 2-AMINO-3- (RENT) -PIRIMIDONA | |
| NO20013665D0 (en) | Potassium salt of (S) -omeprazole | |
| DK1386921T3 (en) | Intermediates for the preparation of anti-thrombotic 4H-cycolopenta-1,3-dioxole derivatives | |
| DK1001934T3 (en) | Indole compounds as COX-2 inhibitors | |
| DK1163207T3 (en) | Improved process for the preparation of non-hygroscopic salts of L (-) - carnitine | |
| DE69900356D1 (en) | Nitro isourea derivatives | |
| NO20003451D0 (en) | 2,3-substituted indole compounds as cox-2 inhibitors | |
| IS5772A (en) | Phthalazine derivatives of phosphodiesterase4 inhibitors | |
| NO20013684D0 (en) | Substituted phenethylamine derivatives | |
| MA24632A1 (en) | DERIVATIVES OF 2- (4-ARYL-OR HETEROARYL-PIPERAZINE-1-YLMETHYLE) -1H- INDOLE | |
| IS5562A (en) | New dihydroxyhexanoic acid derivatives | |
| DE60021384D1 (en) | indole derivatives | |
| IS5166A (en) | Crystallized aqueous sodium salt of (E) -4,6-dichloro-3- (2-oxo-1-phenylpyrrolidin-3-ylidene methyl) -1H-indole-2-carboxylic acid | |
| NO20020306D0 (en) | indole derivatives | |
| IS6434A (en) | New indole derivatives | |
| NO20002904D0 (en) | (E) -3- [1-N-butyl-5- [2- (2-carboxylphenyl) methoxy-4-chlorophenyl] -1H-pyrazol-4-yl] -2 - [(5-methoxy-2,3 -dihydrobenzofuran-6-yl) methyl] -prop-2-enoic acid monoagrinin salt | |
| NO994386D0 (en) | 2-substituted benzoylcycloalkyl-1-carboxylic acid derivatives | |
| EE200100017A (en) | New salts of N-tert-butylhydroxylamine | |
| IT1307734B1 (en) | CARTRIDGE FOR DIALYSIS CONTAINING SODIUM BICARBONATE. |